Gilead Sciences (GILD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist

92.410
+1.060+1.16%

Close Nov 27 16:00 ET

93.000
+0.590+0.64%

Post 20:01 ET

115.17BMarket Cap1026.78P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

RBC Capital Sticks to Their Hold Rating for Gilead Sciences (GILD)
TipRanks20:47 ET · Ratings
Gilead Announces New England Journal of Medicine Publication of PURPOSE 2 Results
Businesswire17:00 ET
Express News | Gilead Announces New England Journal of Medicine Publication of Purpose 2 Results
Reuters17:00 ET
Express News | Form 144 | Gilead Sciences(GILD.US) Officer Proposes to Sell 15.09 Million in Common Stocks
Moomoo News16:20 ET
Wednesday Ends With Index Decline | Wall Street Today
Kevin Travers16:08 ET
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Kevin TraversNov 27 09:57 ET

Comments

$Gilead Sciences (GILD.US)$
low attention stock, just another day!

Share Your Profit/Loss

5

$Gilead Sciences (GILD.US)$ $Merck & Co (MRK.US)$

1

$Gilead Sciences (GILD.US)$

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data

Investment Theme

Cancer Research

Cancer Research

Infectious Disease

Infectious Disease

Mpox (monkeypox)

Mpox (monkeypox)